A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled study drug in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease

June 03, 2016
https://www.clinicaltrials.gov/ct2/show/NCT02630316
Pulmonary Hypertension, Pulmonary
Pulmonary Hypertension, Pulmonary
Open